229 related articles for article (PubMed ID: 38612531)
21. Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.
Tasian SK; Loh ML; Hunger SP
Cancer; 2015 Oct; 121(20):3577-90. PubMed ID: 26194091
[TBL] [Abstract][Full Text] [Related]
22. Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.
Popov A; Tsaur G; Permikin Z; Henze G; Verzhbitskaya T; Plekhanova O; Nokhrina E; Valochnik A; Sibiryakov P; Zerkalenkova E; Olshanskaya Y; Gindina T; Movchan L; Shorikov E; Streneva O; Khlebnikova O; Makarova O; Arakaev O; Boichenko E; Kondratchik K; Ponomareva N; Lapotentova E; Aleinikova O; Miakova N; Novichkova G; Karachunskiy A; Fechina L
Pediatr Blood Cancer; 2023 Apr; 70(4):e30204. PubMed ID: 36715125
[TBL] [Abstract][Full Text] [Related]
23. [Treatment strategy for infants with acute lymphoblastic leukemia].
Miyamura T
Rinsho Ketsueki; 2019; 60(9):1317-1323. PubMed ID: 31597858
[TBL] [Abstract][Full Text] [Related]
24. Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy.
Wu JR; Shih PC; Li C; Chao HL; Wang HC; Chiang YM; Liu YJ; Hsu SC; Yao CY; Chen LH; Lin CC; Tien HF; Chou WC
J Hematop; 2023 Jun; 16(2):103-109. PubMed ID: 38175441
[TBL] [Abstract][Full Text] [Related]
25. Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements.
Wen J; Zhou M; Shen Y; Long Y; Guo Y; Song L; Xiao J
BMC Cancer; 2022 Aug; 22(1):859. PubMed ID: 35933338
[TBL] [Abstract][Full Text] [Related]
26. The future of cellular immunotherapy for childhood leukemia.
Bonifant CL; Tasian SK
Curr Opin Pediatr; 2020 Feb; 32(1):13-25. PubMed ID: 31851053
[TBL] [Abstract][Full Text] [Related]
27. Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cell Transplantation.
Kato M; Hasegawa D; Koh K; Kato K; Takita J; Inagaki J; Yabe H; Goto H; Adachi S; Hayakawa A; Takeshita Y; Sawada A; Atsuta Y; Kato K
Br J Haematol; 2015 Feb; 168(4):564-70. PubMed ID: 25302748
[TBL] [Abstract][Full Text] [Related]
28. PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch.
Nakajima K; Kubota H; Kato I; Isobe K; Ueno H; Kozuki K; Tanaka K; Kawabata N; Mikami T; Tamefusa K; Nishiuchi R; Saida S; Umeda K; Hiramatsu H; Adachi S; Takita J
Cancer Sci; 2022 Jul; 113(7):2472-2476. PubMed ID: 35467057
[TBL] [Abstract][Full Text] [Related]
29. [Treatment strategy for infant acute lymphoblastic leukemia].
Miyamura T
Rinsho Ketsueki; 2022; 63(7):791-798. PubMed ID: 35922950
[TBL] [Abstract][Full Text] [Related]
30. [Treatment strategy for B cell precursor acute lymphoblastic leukemia in children].
Koh K
Rinsho Ketsueki; 2022; 63(7):816-825. PubMed ID: 35922953
[TBL] [Abstract][Full Text] [Related]
31. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
Tran TH; Hunger SP
Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
[TBL] [Abstract][Full Text] [Related]
32. Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia.
Yu CH; Jou ST; Su YH; Coustan-Smith E; Wu G; Cheng CN; Lu MY; Lin KH; Wu KH; Chen SH; Huang FL; Chang HH; Wang JL; Yen HJ; Li MJ; Chou SW; Ho WL; Liu YL; Chang CC; Lin ZS; Lin CY; Chen HY; Ni YL; Lin DT; Lin SW; Yang JJ; Ni YH; Pui CH; Yu SL; Yang YL
Cancer; 2023 Mar; 129(5):790-802. PubMed ID: 36537587
[TBL] [Abstract][Full Text] [Related]
33. Case Report: Rare
Eadie LN; Rehn JA; Breen J; Osborn MP; Jessop S; Downes CEJ; Heatley SL; McClure BJ; Yeung DT; Revesz T; Saxon B; White DL
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833191
[TBL] [Abstract][Full Text] [Related]
34. [Infant acute lymphoblastic leukemia: treatment strategies and new insights].
Miyamura T; Tomizawa D
Rinsho Ketsueki; 2021; 62(11):1567-1575. PubMed ID: 34866078
[TBL] [Abstract][Full Text] [Related]
35. Is acute lymphoblastic leukemia with mature B-cell phenotype and
Hidalgo-Gómez G; Palacio-Garcia C; Gallur L; Blanco A; Tazón-Vega B; Saumell S; Martínez N; Murillo L; Murciano T; Velasco P; Bosch F; Diaz-Heredia C; Ortega M
Leuk Lymphoma; 2021 Sep; 62(9):2202-2210. PubMed ID: 33827367
[TBL] [Abstract][Full Text] [Related]
36. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
Pui CH; Mullighan CG; Evans WE; Relling MV
Blood; 2012 Aug; 120(6):1165-74. PubMed ID: 22730540
[TBL] [Abstract][Full Text] [Related]
37. A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial.
Tomizawa D; Miyamura T; Imamura T; Watanabe T; Moriya Saito A; Ogawa A; Takahashi Y; Hirayama M; Taki T; Deguchi T; Hori T; Sanada M; Ohmori S; Haba M; Iguchi A; Arakawa Y; Koga Y; Manabe A; Horibe K; Ishii E; Koh K
Blood; 2020 Oct; 136(16):1813-1823. PubMed ID: 32845001
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy in pediatric acute lymphoblastic leukemia.
Inaba H; Pui CH
Cancer Metastasis Rev; 2019 Dec; 38(4):595-610. PubMed ID: 31811553
[TBL] [Abstract][Full Text] [Related]
39. Relapsed/Refractory T- Acute Lymphoblastic Leukemia - Current Options and Future Directions.
Jeha S
Indian J Pediatr; 2024 Feb; 91(2):168-175. PubMed ID: 37642889
[TBL] [Abstract][Full Text] [Related]
40. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]